Read + Share
Fjorden K, Ekberg S, Kuric N, Smedby KE, et al. Idelalisib in relapsed/refractory diffuse large B-cell lymphoma: results from a
Nordic Lymphoma Group phase II trial. Br J Haematol 2021 Aug 25. doi: 10.1111/bjh.17792.
PMID: 34435356
|
 |
|
Fjorden K, Ekberg S, Kuric N, Smedby KE, et al. Idelalisib in relapsed/refractory diffuse large B-cell lymphoma: results from a
Nordic Lymphoma Group phase II trial. Br J Haematol 2021 Aug 25. doi: 10.1111/bjh.17792.
PMID: 34435356
|
|
|
|